Immunethep is a biotech startup company that is developing broad coverage anti-bacterial immunotherapies
IMMUNETHEP has raised $1.3M in total funding. The most recent round was Grant. The last funding was announced in March 2025.
IMMUNETHEP's investors include Bill & Melinda Gates Foundation, European Innovation Council, Portugal Ventures, Venture Catalysts, PACE-AMR.
IMMUNETHEP is headquartered in Cantanhede, Portugal.
Immunethep is a biotech startup company that is developing broad coverage anti-bacterial immunotherapies
IMMUNETHEP is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"IMMUNETHEP — Funding & Investors." VCBacked, March 1, 2025, https://www.vcbacked.co/company/immunethep. Accessed August 15, 2026.
VCBacked. (2025). IMMUNETHEP — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/immunethep
{{cite web |title=IMMUNETHEP — Funding & Investors |url=https://www.vcbacked.co/company/immunethep |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated